BlackRock Fund Advisors’s Biocept, Inc. BIOC Stock Holding History

BlackRock Fund Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$24K	Buy	+3	New	+$25.1K	﹤0.01%	3865
2016 Q3	–	Hold	0	–	–	–	4188
2016 Q2	–	Sell	-2	Closed	-$48.4K	–	4188
2016 Q1	$55K	Hold	2	–	–	﹤0.01%	3779
2015 Q4	$63K	Hold	2	–	–	﹤0.01%	3833
2015 Q3	$100K	Hold	2	–	–	﹤0.01%	3702
2015 Q2	$114K	Buy	+2	New	+$154K	﹤0.01%	3712

Other funds holding BIOC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

GCM

Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

BlackRock Fund Advisors's BIOC Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in Biocept, Inc. (BIOC) in Q4 2016: 3 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #3865 among its holdings. This is a return to the name: BlackRock Fund Advisors previously reported a position in BIOC as recently as Q1 2016.

BlackRock Fund Advisors first reported a position in BIOC in Q2 2015 and has held it in 5 quarters since. The position peaked at $114K in Q2 2015. 8 funds tracked by Wall St. Rank hold BIOC as of Q4 2016.

BlackRock Fund Advisors held 3 shares of Biocept, Inc. worth $24K as of Q4 2016.
Biocept, Inc. was a new BlackRock Fund Advisors position in Q4 2016.
Biocept, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3865 holding.
BlackRock Fund Advisors first reported a position in Biocept, Inc. in Q2 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's Biocept, Inc. position peaked at $114K in Q2 2015.
8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.